Frisch Financial Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $728K | Buy |
1,871
+8
| +0.4% | +$3.11K | 0.18% | 67 |
|
2025
Q1 | $810K | Buy |
1,863
+7
| +0.4% | +$3.04K | 0.23% | 56 |
|
2024
Q4 | $685K | Buy |
1,856
+8
| +0.4% | +$2.95K | 0.21% | 56 |
|
2024
Q3 | $961K | Buy |
1,848
+5
| +0.3% | +$2.6K | 0.29% | 48 |
|
2024
Q2 | $999K | Sell |
1,843
-138
| -7% | -$74.8K | 0.3% | 45 |
|
2024
Q1 | $1.03M | Buy |
1,981
+6
| +0.3% | +$3.11K | 0.34% | 40 |
|
2023
Q4 | $931K | Sell |
1,975
-17
| -0.9% | -$8.01K | 0.35% | 43 |
|
2023
Q3 | $867K | Buy |
+1,992
| New | +$867K | 0.35% | 44 |
|
2023
Q1 | – | Sell |
-2,116
| Closed | -$1.09M | – | 123 |
|
2022
Q4 | $1.09M | Buy |
2,116
+5
| +0.2% | +$2.56K | 0.41% | 48 |
|
2022
Q3 | $959K | Buy |
2,111
+6
| +0.3% | +$2.73K | 0.41% | 43 |
|
2022
Q2 | $1.02M | Sell |
2,105
-1
| -0% | -$483 | 0.39% | 42 |
|
2022
Q1 | $1.03M | Sell |
2,106
-179
| -8% | -$87.9K | 0.33% | 48 |
|
2021
Q4 | $1.06M | Sell |
2,285
-109
| -5% | -$50.5K | 0.33% | 51 |
|
2021
Q3 | $892K | Buy |
2,394
+7
| +0.3% | +$2.61K | 0.3% | 50 |
|
2021
Q2 | $912K | Sell |
2,387
-151
| -6% | -$57.7K | 0.29% | 54 |
|
2021
Q1 | $911K | Sell |
2,538
-36
| -1% | -$12.9K | 0.31% | 50 |
|
2020
Q4 | $826K | Buy |
2,574
+108
| +4% | +$34.7K | 0.3% | 42 |
|
2020
Q3 | $662K | Buy |
2,466
+9
| +0.4% | +$2.42K | 0.29% | 47 |
|
2020
Q2 | $646K | Buy |
2,457
+9
| +0.4% | +$2.37K | 0.31% | 41 |
|
2020
Q1 | $556K | Sell |
2,448
-113
| -4% | -$25.7K | 0.32% | 46 |
|
2019
Q4 | $773K | Buy |
2,561
+7
| +0.3% | +$2.11K | 0.37% | 44 |
|
2019
Q3 | $613K | Buy |
2,554
+204
| +9% | +$49K | 0.37% | 43 |
|
2019
Q2 | $663K | Buy |
2,350
+13
| +0.6% | +$3.67K | 0.44% | 40 |
|
2019
Q1 | $671K | Sell |
2,337
-173
| -7% | -$49.7K | 0.41% | 47 |
|
2018
Q4 | $659K | Buy |
+2,510
| New | +$659K | 0.46% | 49 |
|